Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 27 M29 M — Research & development —— — Operating income -176 M-254 M — Non-Operating Income, Total -47 M-13 M — Interest expense, net of interest capitalized —3 M — Non-Operating Income, excl. Interest Expenses -46 M-16 M — Unusual income/expense -1 M0 — Pretax income -223 M-267 M — Equity in earnings —— — Taxes -26 M-21 M — Non-controlling/minority interest -120 M-143 M — After tax other income/expense —— — Net income before discontinued operations -77 M-103 M — Discontinued operations —— — Net income -77 M-103 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -78 M-103 M — Basic earnings per share (Basic EPS) -0.52-0.73 — Diluted earnings per share (Diluted EPS) -0.52-0.72 — Average basic shares outstanding 148.88 M142.53 M — Diluted shares outstanding 148.93 M142.53 M — EBITDA 6 M-20 M — EBIT -176 M-254 M — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 182 M234 M —